Genes are expressed through tightly controlled processes. The first step of gene expression is transcription, a cellular process by which a gene's DNA sequence is copied into RNA. Transcriptional bursting is a fundamental property of genes that allows large amounts of RNA to be produced in a short period of time. This process has been observed in diverse organisms, from bacteria to mammals. In this study, the researchers applied mathematical modeling to single-cell RNA sequencing data—information on the transcriptional activity of individual cells—to infer transcriptional bursting dynamics under multiple conditions. The researchers found that Mediator complex subunit 26 (MED26) had the most profound impact on the entire gene regulatory network, acting downstream of chromatin spatial architecture without affecting TATA box-binding protein recruitment, a key step that helps recruits transcription machinery to the gene. These findings suggest that later steps in the initiation of transcriptional bursts are primary nodes for integrating gene networks in single cells.

Neutrophil depletion and deregulation are directly linked to development of diabetic foot ulcers (DFU). Scientists used a streptozotocin-treated hyperglycemic (high blood glucose/sugar) mouse model to study how overexpression of SOX2 in the skin affects wound healing. The researchers found that the combination of SOX2 upregulation and hyperglycemia in skin cells called keratinocytes triggers a pro-healing signature and increased neutrophil migration. The results highlight SOX2-mediated gene expression as a potential means of addressing neutrophil depletion in DFU.

This study examines how a specific metabolic pathway, called the Aconitate Decarboxylase 1/Itaconate pathway, affects the immune system in people with systemic lupus erythematosus (SLE). The researchers found that this pathway is involved in the immune system dysfunction in animal models of lupus and is also linked to markers that indicate heart disease risk and lupus disease activity levels in people with SLE.

The metabolic enzyme PKM2 accumulates in the nucleus in various cancer cells. In this study, researchers found that PKM2 binds to structures called G-quadruplexes (rG4) forming on precursor mRNAs. The balance of folded and unfolded rG4s controls the transcriptional output of rG4-containing RNAs (rG4ome). The rG4ome encodes components related to epithelial-to-mesenchymal transition (e.g., a process that allows tumors to grow and spread) and higher rG4 levels, which are associated with poorer patient survival outcomes in different cancer types. Further, removing PKM2 from the nucleus reduces tumor growth and metastasis.